Upstream Bio, Inc.
NASDAQ:UPB · NASDAQ Global Select
+$0.10 today
Vol 0.79M · Avg 0.66M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-41.70%
Period High
$32.60
Period Low
$5.92
Latest
$6.25
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Spyre Therapeutics, Inc.
NASDAQ:SYRE
$5.34B
Terns Pharmaceuticals, Inc.
TERN
$4.77B
Relay Therapeutics, Inc.
NASDAQ:RLAY
$2.78B
Pharvaris N.V.
NASDAQ:PHVS
$2.29B
Intellia Therapeutics, Inc.
NASDAQ:NTLA
$1.76B
Syndax Pharmaceuticals, Inc.
NASDAQ:SNDX
$1.68B
Novavax, Inc.
NASDAQ:NVAX
$1.50B
Amylyx Pharmaceuticals, Inc.
NASDAQ:AMLX
$1.30B
Wave Life Sciences Ltd.
NASDAQ:WVE
$1.19B
Zenas BioPharma, Inc.
NASDAQ:ZBIO
$883.04M
What is the latest UPB filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does UPB have?
Intrinsic Alpha currently shows 20 recent filings for UPB.
Explore More
Continue the stock analysis
Jump to another research area for this company.